PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study.

Diabetes Ther · 2017 · PMC5380508 · PMID 28361462

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

a significant trendP < 0.01actually significant

A significant trend was observed for BMI, HDL-C, LDL-C, TG, FFA, FBG, 2hPG, HbA1c, FINS, and hsCRP among the three groups (BMI, HDL-C, FBG, 2hPG, HbA1c, and FINS: P < 0.01; LDL-C, TG, FFA, and hsCRP: P < 0.05).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.